Profitability Metrics

Gross Margin
29.47%
Operating Margin
25.04%
Net Margin
5.76%

Efficiency Metrics

Revenue per Expense Ratio
1.33
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
25.41%
Income Tax Rate
1.61%
EPS
0.3200000000

Balance Sheet Analysis

Current Ratio
19.64
Cash Ratio
16.01
Working Capital
$601.66M
Debt to Equity
1.00
Debt to Assets
47.64%
Equity Ratio
47.50%

Cash Flow Analysis

Operating Cash Flow Ratio
23.77%
Free Cash Flow Ratio
13.79%
CapEx to Revenue
9.98%
Dividends Paid
$74.31M
Stock Buybacks
$80.37M
Total Shareholder Returns
$154.68M
Cash Position Change
3.53%

Key Takeaways (2023 FY)

  • Maintained positive net income growth despite revenue changes
  • Increased dividend payments by 100.97%

Detailed Growth Metrics

Core Performance

Revenue
11.05%
Net Income
82.24%
EPS
23.08%
Operating Income
144.81%

Operational Efficiency

R&D Expenses
-100.00%
SG&A Expenses
4.74%
Operating Cash Flow
22.85%
Free Cash Flow
138.32%

Balance Sheet Health

Assets
-1.18%
Debt
0.38%
Book Value per Share
0.53%
Inventory
-100.00%

Shareholder Returns

Dividends per Share
100.97%
Shares Outstanding
-3.72%

Long Term Trends

3Y Revenue/Share
195.61%
5Y Revenue/Share
-15.90%
3Y Dividend/Share
-8.97%
5Y Dividend/Share
-67.79%